Atosiban Impurity F is a defined related substance formed during atosiban synthesis or degradation. Structural deviations modify conformational preferences and chromatographic retention. Researchers use it to validate specificity in analytical methods and to understand degradation pathways. Applications include impurity profiling, stability testing, and peptide-process optimization.
CAT No: Z10-101-221
Synonyms/Alias:(5-amino-2-((S)-1-(((R)-3-(4-ethoxyphenyl)-2-(3-mercaptopropanamido)propanoyl)-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl)pyrrolidine-2-carboxamido)pentanoyl)glycine; 2-((S)-5-amino-2-((S)-1-((2R,5S,8S,11S,14R)-5-(2-amino-2-oxoethyl)-11-((S)-sec-butyl)-14-(4-ethoxybenzyl)-8-((R)-1-hydroxyethyl)-18-mercapto-2-(mercaptomethyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oyl)pyrrolidine-2-carboxamido)pentanamido)acetic acid
Atosiban impurity F is a specialized carbohydrate compound often encountered as a process-related byproduct during the synthesis of atosiban, an oxytocin receptor antagonist peptide. Characterized by its unique molecular structure, Atosiban impurity F presents distinct analytical challenges and opportunities for researchers focused on peptide synthesis, pharmaceutical development, and quality control. Its presence in synthetic pathways necessitates precise identification and quantification to ensure the integrity of the target compound, making it a valuable reference material in analytical laboratories. Due to its structural similarity to the parent molecule, this impurity serves as a critical marker for evaluating process efficiency and optimizing purification strategies in peptide manufacturing.
Analytical Method Development: Atosiban impurity F is frequently utilized as a reference standard in the development and validation of chromatographic and spectrometric methods. Laboratories employ it to calibrate high-performance liquid chromatography (HPLC) and mass spectrometry (MS) systems, ensuring accurate detection and quantification of process-related impurities in peptide batches. Its well-characterized profile aids in establishing method specificity and sensitivity, which are essential for robust quality control protocols and regulatory documentation. By incorporating this impurity into method development workflows, scientists can confidently assess the selectivity of their analytical techniques, minimize false positives, and enhance the reproducibility of their results.
Process Optimization in Peptide Synthesis: The presence of Atosiban impurity F in synthetic processes provides valuable insights into reaction mechanisms and side-product formation. Researchers use its detection as an indicator of incomplete reactions or suboptimal reaction conditions, enabling them to refine synthesis parameters such as reagent concentrations, reaction times, and purification steps. By monitoring this impurity, chemists can systematically reduce its formation, thereby improving the overall yield and purity of the desired peptide. This approach not only streamlines manufacturing efficiency but also supports the development of scalable and cost-effective synthetic routes for complex peptides.
Impurity Profiling and Risk Assessment: Comprehensive impurity profiling is a cornerstone of pharmaceutical development, and Atosiban impurity F plays a pivotal role in this context. Scientists investigate its formation pathways, stability, and potential interactions with other components in the formulation matrix. Such studies contribute to a deeper understanding of the impurity's behavior under various storage and processing conditions, informing risk assessments and guiding decisions on acceptable impurity levels. By elucidating the fate of this byproduct, researchers can better anticipate potential challenges in downstream processing and long-term product stability.
Reference Material for Stability Studies: Atosiban impurity F is also employed as a reference material in forced degradation and stability studies of peptide products. By intentionally introducing this impurity into stability samples, analysts can evaluate the robustness of storage conditions and packaging materials. Tracking its concentration over time enables the identification of degradation pathways and the assessment of product shelf life. These studies are instrumental in defining optimal storage guidelines and ensuring the consistent quality of peptide therapeutics throughout their lifecycle.
Comparative Structural Analysis: The structural features of Atosiban impurity F make it an ideal candidate for comparative studies involving advanced spectroscopic and computational techniques. Researchers utilize it to investigate structure-activity relationships (SAR) and to validate analytical methodologies such as nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy. These comparative analyses facilitate the identification of subtle structural differences between the impurity and the parent peptide, enhancing the precision of impurity identification and supporting the continuous improvement of analytical workflows. Through its multifaceted applications, Atosiban impurity F serves as an indispensable tool for scientists dedicated to the advancement of peptide research, manufacturing, and quality assurance.
1. Myotropic activity of allatostatins in tenebrionid beetles
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More